Takeda Failed To Warn Of Actos Cancer Risk, Jury Hears
Japan's Takeda Pharmaceutical Co. should have added a bladder cancer warning to its diabetes drug Actos long before a man now dying of the disease began taking the medication, his attorney...To view the full article, register now.
Already a subscriber? Click here to view full article